Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/23/2003WO2003087758A2 Peptides for detection of antibody to a. phagocytophila
10/23/2003WO2003087565A2 Propellant test apparatus and method
10/23/2003WO2003087550A1 Method and apparatus for controlling a gas-emitting process and related devices
10/23/2003WO2003087412A2 Mutation detection and identification
10/23/2003WO2003087410A1 Methods and devices for performing chemical reactions on a solid support
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
10/23/2003WO2003087404A1 Methods to predict patient responsiveness to tyrosine kinase inhibitors
10/23/2003WO2003087401A1 High-density lipoprotein assay device and method
10/23/2003WO2003087400A1 Methods and reagents for assaying protein kinase activity
10/23/2003WO2003087399A1 Nad)p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
10/23/2003WO2003087397A2 Process control based on microbiological activity
10/23/2003WO2003087395A2 Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions
10/23/2003WO2003087391A2 Hydrophobic zone device
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087366A1 Endocrine cell lines and method of using the same
10/23/2003WO2003087365A1 Method of measuring human cyp3a inducibility
10/23/2003WO2003087364A1 Novel g protein-coupled receptor and its gene
10/23/2003WO2003087356A2 Helicokinin-receptor from insects
10/23/2003WO2003087353A2 Purified polypeptides involved in membrane biogenesis
10/23/2003WO2003087349A1 METHOD OF FORMING PANCREATIC β CELLS FROM MESENCHYMAL CELLS
10/23/2003WO2003087347A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087342A2 Reducing non-specific binding in immunoassays performed on polymeric solid phases
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003WO2003087314A2 Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
10/23/2003WO2003087310A2 Directed protein docking algorithm
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003087299A2 Methods of characterizing molecular interaction sites on proteins
10/23/2003WO2003087293A1 Apparatus and method for biochemical analysis
10/23/2003WO2003087289A2 Methods for the selection of compounds useful for the treatment of huntington’s disease
10/23/2003WO2003087158A2 Regulation of human transient receptor potential channel
10/23/2003WO2003087155A1 Novel protein and dna thereof
10/23/2003WO2003087152A1 Luminescent markers
10/23/2003WO2003087135A2 Novel pheromone receptor
10/23/2003WO2003087134A2 G-protein coupled receptor ligands and methods
10/23/2003WO2003087133A2 Improved methods for high-resolution identification of solvent-accessible amide hydrogens in polypeptides and for characterization of polypeptide structure
10/23/2003WO2003087132A2 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity
10/23/2003WO2003087129A2 Immunogenic peptides, and method of identifying same
10/23/2003WO2003087123A2 Methods and kits for testing mutagenicity
10/23/2003WO2003087104A1 Heterocyclic compounds
10/23/2003WO2003087102A1 Furyl compounds
10/23/2003WO2003087054A2 Methods for identifying compounds that modulate enzymatic activity
10/23/2003WO2003087051A2 Methods for identifying allosteric sites
10/23/2003WO2003086637A1 Immunoassay probe
10/23/2003WO2003086505A1 Access disconnection systems and methods
10/23/2003WO2003086475A1 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003086461A2 Use of substances for treating tumors
10/23/2003WO2003086453A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003WO2003086446A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003WO2003086445A1 Serum biomarkers in hepatocellular carcinoma
10/23/2003WO2003086431A1 Virally infected plants as a source of insect reppelants/attractents
10/23/2003WO2003086373A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086292A2 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening
10/23/2003WO2003086285A2 Live cell method for observing cellular processes
10/23/2003WO2003086284A2 Colon tumor specific binding peptides
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086278A2 Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
10/23/2003WO2003086277A2 Attenuated gram negative bacteria
10/23/2003WO2003086233A2 Thermal monitoring of tissue perfusion with recalibration.
10/23/2003WO2003086199A2 A sample surface component for an instrument that measures viscosity and viscoelasticity
10/23/2003WO2003086197A1 Detecting interactions at biomimetic interfaces with liquid crystals
10/23/2003WO2003086177A2 Method for monitoring the immune response and predicting clinical outcomes in transplant recipients
10/23/2003WO2003086176A2 Observation of effects of body fluids on indicator cells for disease diagnosis
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086174A2 A new method for the diagnosis and prognosis of malignant diseases
10/23/2003WO2003072812A3 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
10/23/2003WO2003068947A8 Assay electrodes having immobilized lipid/protein layers and methods of making and using the same
10/23/2003WO2003065972A3 Methods for screening osteogenic compounds
10/23/2003WO2003060807A3 Methods for determining polypeptide structure, function or pharmacophore from comparison of polypeptide sequences
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003055914A3 Modified receptors for the discovery of therapeutic ligands
10/23/2003WO2003055899A3 Oxidized fungal antigens and methods of making and using thereof
10/23/2003WO2003049851A3 Microarray device
10/23/2003WO2003048773A3 Methods for monitoring amyotrophic lateral sclerosis
10/23/2003WO2003046054A3 Copolymer libraries and production and use thereof
10/23/2003WO2003044217A3 Automated sample preparation methods and devices
10/23/2003WO2003040287A3 Isotope-coded affinity tag
10/23/2003WO2003040024A3 Assay based on doped nanoparticles
10/23/2003WO2003033663A3 Rankl mimics and uses thereof
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003020873A3 Reproduction of ribonucleic acids
10/23/2003WO2003018775A3 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays
10/23/2003WO2003017755A3 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
10/23/2003WO2003016466A3 ANTI-Aβ ANTIBODIES
10/23/2003WO2003014382A3 Device for analyzing nucleic acid
10/23/2003WO2003012721A3 Prediction models for molecular activity and protein binding
10/23/2003WO2003012449A3 Method for selecting antibody expressing cells
10/23/2003WO2003010278A3 Automated process for detecting pathogenic organisms in water
10/23/2003WO2003008535A3 Methods of generating human cardiac cells and tissues and uses thereof
10/23/2003WO2003006676A3 Method for immobilizing molecules onto surfaces
10/23/2003WO2003005888A3 Lipophilin complexes for use in cancer diagnosis and therapy
10/23/2003WO2003005023A3 Method for determining the interaction between keratinocytes and neurons
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002094248A3 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
1 ... 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 ... 3937